Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > one treatment only

<< Previous

Bullboard Posts

Next >>

Post by DJDawgon Aug 13, 2024 12:58pm

607 Views

Post# 36176820

one treatment only

One tiny detail in the swimmers is that three patients only got one treatment (no 6month one) and showed CR and sustained CR so far.

You can tell as they indicate a star when they get another treatment.

I really hope that they highlight that in the BTD as one and done is unheard of in this treatment space.

The star system that they have also shows that there don't seem to be many takers for an add-on treatment that was approved in the protocol update recently.

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market